Mycobacterium triplex pulmonary disease in immunocompetent host

Emerg Infect Dis. 2004 Oct;10(10):1859-62. doi: 10.3201/eid1010.040217.

Abstract

Mycobacterium triplex, a recently described, potentially pathogenic species, caused disease primarily in immunocompromised patients. We report a case of pulmonary infection due to this mycobacterium in an immunocompetent patient and review the characteristics of two other cases. In our experience, Mycobacterium triplex pulmonary infection is unresponsive to antimycobacterial chemotherapy.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Base Sequence
  • DNA, Bacterial / analysis
  • Female
  • Humans
  • Immunocompetence
  • Lung Diseases / microbiology*
  • Middle Aged
  • Molecular Sequence Data
  • Mycobacterium Infections / drug therapy
  • Mycobacterium Infections / immunology
  • Mycobacterium Infections / microbiology*
  • Mycobacterium* / classification
  • RNA, Ribosomal, 16S / genetics
  • Sequence Analysis, DNA
  • Species Specificity

Substances

  • Anti-Bacterial Agents
  • DNA, Bacterial
  • RNA, Ribosomal, 16S